Melatonin inhibits Prevotella intermedia lipopolysaccharide-induced production of nitric oxide and interleukin-6 in murine macrophages by suppressing NF-κB and STAT1 activity

Journal of Pineal Research

Volumn 50, Issue 2, 2011, Pages 197-206

  Choi, Eun Young ^a   Jin, Ji Young ^a   Lee, Ju Youn ^b   Choi, Jeom Il ^b   Choi, In Soon ^a   Kim, Sung Jo ^b  

^a Silla University   (South Korea)

^b Pusan National University   (South Korea)

Author keywords

interleukin 6; lipopolysaccharide; melatonin; nitric oxide; periodontal disease; Prevotella intermedia

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; MELATONIN; NITRIC OXIDE; STAT1 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA BINDING; DRUG MECHANISM; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; HORMONE INHIBITION; IMMUNE DEFICIENCY; IMMUNOMODULATION; INFLAMMATION; MACROPHAGE; MEDIATOR RELEASE; MOUSE; NONHUMAN; PERIODONTAL DISEASE; PERIODONTIUM; PREVOTELLA INTERMEDIA; PROTEIN DEGRADATION; RNA TRANSLATION; SIGNAL TRANSDUCTION;

ANIMALS; BLOTTING, WESTERN; CELL LINE; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES; MELATONIN; MICE; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; POLYMERASE CHAIN REACTION; PREVOTELLA INTERMEDIA; STAT1 TRANSCRIPTION FACTOR;

EID: 79951645465     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2010.00829.x     Document Type: Article

References (68)

1. Williams RC,. Periodontal disease. N Engl J Med 1990; 322: 373-381.
2. Pihlstrom BL, Michalowicz BS, Johnson NW,. Periodontal diseases. Lancet 2005; 366: 1809-1820. (Pubitemid 41642647)
3. Teng YT, Taylor GW, Scannapieco F, et al. Periodontal health and systemic disorders. J Can Dent Assoc 2002; 68: 188-192.
4. Seymour GJ, Ford PJ, Cullinan MP, et al. Relationship between periodontal infections and systemic disease. Clin Microbiol Infect 2007; 13: 3-10. (Pubitemid 47308185)
5. Slots J, Bragd L, Wikstrom M, et al. The occurrence of Actinobacillus actinomycetemcomitans, Bacteroides gingivalis and Bacteroides intermedius in destructive periodontal disease in adults. J Clin Periodontol 1986; 13: 570-577.
6. Tanner ACR, Haffer C, Bratthall GT, et al. A study of the bacteria associated with advancing periodontitis in man. J Clin Periodontol 1979; 6: 278-307. (Pubitemid 10191673)
7. Chung CP, Nisengard RJ, Slots J, et al. Bacterial IgG and IgM antibody titers in acute necrotizing ulcerative gingivitis. J Periodontol 1983; 54: 557-562.
8. Kornman KS, Loesche WJ,. The subgingival microbial flora during pregnancy. J Periodont Res 1980; 15: 111-122. (Pubitemid 10181867)
9. Morrison DC, Ryan JL,. Endotoxins and disease mechanisms. Annu Rev Med 1987; 38: 417-432.
10. Geller DA, Nussler AK, Di Silvio M, et al. Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc Natl Acad Sci USA 1993; 90: 522-526. (Pubitemid 23028895)
11. Nathan C, Xie QW,. Regulation of biosynthesis of nitric oxide. J Biol Chem 1994; 269: 13725-13728. (Pubitemid 24191108)
12. Moncada S, Palmer RMJ, Higgs EA,. Nitric oxide: physiology, pathology, and pharmacology. Pharmacol Rev 1991; 43: 109-142.
13. Southey A, Tanaka S, Murakami T, et al. Pathophysiological role of nitric oxide in rat experimental colitis. Int J Immunopharmacol 1997; 19: 669-676. (Pubitemid 28270801)
14. Weinberg JB, Granger DL, Pisetsky DS, et al. The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally administered NG-monomethyl-L-arginine. J Exp Med 1994; 179: 651-660.
15. Hamada S, Takada H, Ogawa T, et al. Lipopolysaccharides of oral anaerobes associated with chronic inflammation: chemical and immunomodulating properties. Int Rev Immunol 1990; 6: 247-261.
16. Kirikae T, Nitta T, Kirikae F, et al. Lipopolysaccharides (LPS) of oral black-pigmented bacteria induce tumor necrosis factor production by LPS-refractory C3H/HeJ macrophages in a way different from that of Salmonella LPS. Infect Immun 1999; 67: 1736-1742. (Pubitemid 29144391)
17. Hashimoto M, Asai Y, Tamai R, et al. Chemical structure and immunobiological activity of lipid A from Prevotella intermedia ATCC 25611 lipopolysaccharide. FEBS Lett 2003; 543: 98-102. (Pubitemid 36577235)
18. Preshaw PM,. Host response modulation in periodontics. Periodontol 2000 2008; 48: 92-110.
19. Salvi GE, Lang NP,. Host response modulation in the management of periodontal diseases. J Clin Periodontol 2005; 32 (Suppl 6): 108-129. (Pubitemid 41391060)
20. Reddy MS, Geurs NC, Gunsolley JC,. Periodontal host modulation with antiproteinase, anti-inflammatory, and bone-sparing agents. A systematic review. Ann Periodontol 2003; 8: 12-37.
21. Blix IJ, Helgeland K,. LPS from Actinobacillus actinomycetemcomitans and production of nitric oxide in murine macrophages J774. Eur J Oral Sci 1998; 106: 576-581. (Pubitemid 128736230)
22. Sosroseno W, Barid I, Herminajeng E, et al. Nitric oxide production by a murine macrophage cell line (RAW264.7) stimulated with lipopolysaccharide from Actinobacillus actinomycetemcomitans. Oral Microbiol Immunol 2002; 17: 72-78.
23. Kim SJ, Ha MS, Choi EY, et al. Prevotella intermedia lipopolysaccharide stimulates release of nitric oxide by inducing expression of inducible nitric oxide synthase. J Periodont Res 2004; 39: 424-431.
24. Kim SJ, Ha MS, Choi EY, et al. Nitric oxide production and inducible nitric oxide synthase expression induced by Prevotella nigrescens lipopolysaccharide. FEMS Immunol Med Microbiol 2005; 43: 51-58.
25. Kim SJ, Choi EY, Kim EG, et al. Prevotella intermedia lipopolysaccharide stimulates release of tumor necrosis factor-alpha through mitogen-activated protein kinase signaling pathways in monocyte-derived macrophages. FEMS Immunol Med Microbiol 2007; 51: 407-413. (Pubitemid 47547516)
26. Reiter RJ,. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr Rev 1991; 12: 151-180.
27. Tan DX, Manchester LC, Reiter RJ, et al. Identification of highly elevated levels of melatonin in bone marrow: its origin and significance. Biochim Biophys Acta 1999; 1472: 206-214. (Pubitemid 29486531)
28. Simonneaux V, Ribelayga C,. Generation of the melatonin endocrine message in mammals: a review of the complex regulation of melatonin synthesis by norepinephrine, peptides and other pineal transmitters. Pharmacol Rev 2003; 55: 325-395. (Pubitemid 36666050)
29. Tan DX, Chen LD, Poeggeler B, et al. Melatonin: a potent endogenous hydroxyl radical scavenger. Endocr J 1993; 1: 57-60.
30. Paradies G, Petrosillo G, Paradies V, et al. Melatonin, cardiolipin and mitochondrial bioenergetics in health and disease. J Pineal Res 2010; 48: 297-310.
31. Jung-Hynes B, Reiter RJ, Ahmad N,. Sirtuins, melatonin and circadian rhythms: building a bridge between aging and cancer. J Pineal Res 2010; 48: 9-19.
32. Guerrero JM, Reiter RJ,. Melatonin-immune system relationships. Curr Top Med Chem 2002; 2: 167-179.
33. Westphal O, Jann K,. Bacterial lipopolysaccharides: extraction with phenol-water and further applications of the procedure. In: Methods in Carbohydrate Chemistry, Whistler RL, ed., Academic Press, New York, 1965; pp. 83-91.
34. Markwell MA, Haas SM, Bieber LL, et al. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 1978; 87: 206-210. (Pubitemid 9050428)
35. Mosmann T,. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63. (Pubitemid 14203433)
36. Green LC, Wagner DA, Glogowski J, et al. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 1982; 126: 131-138. (Pubitemid 13203451)
37. Kaur H, Halliwell B,. Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheumatoid patients. FEBS Lett 1994; 350: 9-12.
38. Rachmilewitz D, Stamler JS, Bachwich D, et al. Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohns disease. Gut 1995; 6: 718-723.
39. Nishimoto N,. Interleukin-6 in rheumatoid arthritis. Curr Opin Rheumatol 2006; 18: 277-281. (Pubitemid 43740380)
40. Stoufi ED, Taubman MA, Ebersole JL, et al. Phenotypic analyses of mononuclear cells recovered from healthy and diseased human periodontal tissues. J Clin Immunol 1987; 7: 235-245. (Pubitemid 17095450)
41. Cutando A, Gõmez-Moreno G, Arana C, et al. Melatonin: potential functions in the oral cavity. J Periodontol 2007; 78: 1094-1102.
42. Roth JA, Kim BG, Lin WL, et al. Melatonin promotes osteoblast differentiation and bone formation. J Biol Chem 1999; 274: 22041-22047.
43. Nakade O, Koyama H, Ariji H, et al. Melatonin stimulates proliferation and type I collagen synthesis in human bone cells in vitro. J Pineal Res 1999; 27: 106-110. (Pubitemid 29440990)
44. Srinath R, Acharya AB, Thakur SL,. Salivary and gingival crevicular fluid melatonin in periodontal health and disease. J Periodontol 2010; 81: 277-283.
45. Cutando A, Galindo P, Gõmez-Moreno G, et al. Relationship between salivary melatonin and severity of periodontal disease. J Periodontol 2006; 77: 1533-1538. (Pubitemid 44740763)
46. Matejka M, Partyka L, Ulm C, et al. Nitric oxide synthesis is increased in periodontal disease. J Periodont Res 1998; 33: 517-518. (Pubitemid 128527355)
47. Batista AC, Silva TA, Chun JH, et al. Nitric oxide synthesis and severity of human periodontal disease. Oral Dis 2002; 8: 254-260.
48. Hirose M, Ishihara K, Saito A, et al. Expression of cytokines and inducible nitric oxide synthase in inflamed gingival tissue. J Periodontol 2001; 72: 590-597. (Pubitemid 33606325)
49. Kendall HK, Haase HR, Li H, et al. Nitric oxide synthase type-II is synthesized by human gingival tissue and cultured human gingival fibroblasts. J Periodont Res 2000; 35: 194-200.
50. Lappin DF, Kjeldsen M, Sander L, et al. Inducible nitric oxide synthase expression in periodontitis. J Periodont Res 2000; 35: 369-373.
51. Geivelis M, Turner DW, Pederson ED, et al. Measurements of interleukin-6 in gingival crevicular fluid from adults with destructive periodontal disease. J Periodontol 1993; 64: 980-983.
52. Mogi M, Otogoto J, Ota N, et al. Interleukin 1β, interleukin 6, β2-microglobulin, and transforming growth factor-α in gingival crevicular fluid from human periodontal disease. Arch Oral Biol 1999; 44: 535-539. (Pubitemid 29264475)
53. Tamura T, Udagawa N, Takahashi N, et al. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. Proc Natl Acad Sci USA 1993; 90: 11924-11928. (Pubitemid 24008752)
54. Liu XH, Kirschenbaum A, Yao S, et al. Cross-talk between the interleukin-6 and prostaglandin E(2) signaling systems results in enhancement of osteoclastogenesis through effects on the osteoprotegerin/receptor activator of nuclear factor-{kappa}B (RANK) ligand/RANK system. Endocrinology 2005; 146: 1991-1998. (Pubitemid 40396909)
55. Baeuerle PA, Henkel T,. Function and activation of NF-kappaB in the immune system. Annu Rev Immunol 1994; 12: 141-179.
56. Rothwarf DM, Karin M,. The NF-kappa B activation pathway: a paradigm in information transfer from membrane to nucleus. Sci STKE 1999; 999: RE1.
57. Karin M, Ben-Neriah Y,. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol 2000; 18: 621-663. (Pubitemid 30365393)
58. Covert MW, Leung TH, Gaston JE, et al. Achieving stability of lipopolysaccharide-induced NF-kappaB activation. Science 2005; 309: 1854-1857. (Pubitemid 41325095)
59. Li Q, Verma IM,. NF-kappaB regulation in the immune system. Nat Rev Immunol 2002; 2: 725-734.
60. Mohan N, Sadeghi K, Reiter RJ, et al. The neurohormone melatonin inhibits cytokine, mitogen and ionizing radiation induced NF-kappa B. Biochem Mol Biol Int 1995; 37: 1063-1070. (Pubitemid 26181750)
61. Chuang JI, Mohan N, Meltz ML, et al. Effect of melatonin on NF-kappa-B DNA-binding activity in the rat spleen. Cell Biol Int 1996; 20: 687-692. (Pubitemid 26402163)
62. Hayden MS, Ghosh S,. Signaling to NF-κB. Genes Dev 2004; 18: 2195-2224.
63. Ghosh S, May MJ, Kopp EB,. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998; 16: 225-260. (Pubitemid 28183365)
64. Pfitzner E, Kliem S, Baus D, et al. The role of STATs in inflammation and inflammatory diseases. Curr Pharm Des 2004; 10: 2839-2850. (Pubitemid 39162402)
65. Schindler C, Darnell JE Jr,. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu Rev Biochem 1995; 64: 621-651.
66. Yamaoka K, Saharinen P, Pesu M, et al. The Janus kinases (Jaks). Genome Biol 2004; 5: 253.
67. Schindler C, Levy DE, Decker T,. JAK-STAT signaling: from interferons to cytokines. J Biol Chem 2007; 282: 20059-20063. (Pubitemid 47099977)
68. Gao JJ, Filla MB, Fultz MJ, et al. Autocrine/paracrine IFN-αβ mediates the lipopolysaccharide-induced activation of transcription factor Stat1α in mouse macrophages: pivotal role of Stat1α in induction of the inducible nitric oxide synthase gene. J Immunol 1998; 161: 4803-4810. (Pubitemid 28492057)